Skip to main content
Cancer Science logoLink to Cancer Science
. 2017 Feb 28;108(2):277–278. doi: 10.1111/cas.13195

Correction

PMCID: PMC5329149  PMID: 28244253

The authors would like to draw the reader's attention to errors in the following article:

Tsai M‐M, Lin PY, Cheng W‐L, Tsai C‐Y, Chi H‐C, Chen C‐Y, Tseng Y‐H, Cheng Y‐F, Chen C‐D, Liang Y, Liao C‐J, Wu S‐M, Lin Y‐H, Chung I‐H, Wang C‐S, Lin K‐H. Overexpression of ADP‐ribosylation factor 1 in human gastric carcinoma and its clinicopathological significance. Cancer Sci 2012; 103: 1136–44.

In Figure 4(D), two control images (control‐1 and control‐2) were identical. The correct Figure 4(D) image is shown below.

graphic file with name CAS-108-277-g001.jpg

In Table 2, the table header ‘No.’ should read ‘5‐yr S.R.’. The original column for the ‘No.’ header was missing. The correct Table 2 is shown below.

Table 2.

Analysis of risk factors for 5‐year survival rate in 110 gastric cancer patients

Risk factors No. 5‐yr S.R. Univariate analysis P Multivariate analysis§
HR 95% CI P
ARF1 (IHC ≥ 90 score)
Low expression 50 62.9 0.0288 1.987 1.045–3.776 0.036
High expression 60 40.9
Gross type
Localized 43 78.8 <0.0001 0.556 0.214–1.441 NS
Infiltrative 67 31.0
Size (cm)
<5 60 69.3 <0.0001 1.986 0.929–4.247 NS
≥5 50 25.3
Histological type
Intestinal 41 72.2 0.0001 2.063 0.924–4.607 NS
Diffuse 69 36.7
Serosal invasion
No (T1, T2) 43 82.3 <0.0001 1.584 0.578–4.340 NS
Yes (T3, T4) 72 30.3
Lymph node metastasis
No (N0) 32 93.7 <0.0001 9.985 1.913–52.125 0.006
Yes (N1, N2, N3) 78 32.4
Distant metastasis (pM)
No 85 64.0 <0.0001 2.502 1.071–5.848 0.034
Yes 25 4.2
Peritoneal seeding
No 91 59.6 <0.0001 1.070 0.441–2.597 NS
Yes 19 5.6
Vascular invasion
No 91 57.7 <0.0001 1.435 0.726–2.836 NS
Yes 19 12.1
Lymphatic invasion
No 45 79.2 <0.0001 0.769 0.295–2.004 NS
Yes 65 29.5
Perineural invasion
No 71 64.9 <0.0001 1.138 0.589–2.197 NS
Yes 39 22.7

†Five‐year survival rate; ‡Log rank test, P value < 0.05; §Cox regression method, P value < 0.05; ¶Multivariate‐adjusted hazard ratio (HR). CI, Confidence interval; NS, not significant.

The authors apologize for these errors and any confusion these may have caused.


Articles from Cancer Science are provided here courtesy of Wiley

RESOURCES